(3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-[2-[(2R)-oxan-2-yl]pyrazol-3-yl]-1,7-naphthyridin-2-yl]morpholine;(3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-[2-[(2S)-oxan-2-yl]pyrazol-3-yl]-1,7-naphthyridin-2-yl]morpholine

C50H58N14O4 — CID 159119539

IUPAC(3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-[2-[(2R)-oxan-2-yl]pyrazol-3-yl]-1,7-naphthyridin-2-yl]morpholine;(3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-[2-[(2S)-oxan-2-yl]pyrazol-3-yl]-1,7-naphthyridin-2-yl]morpholine
SMILESC[C@@H]1COCCN1c1cc(-c2ccnn2C)c2ccnc(-c3ccnn3[C@@H]3CCCCO3)c2n1.C[C@@H]1COCCN1c1cc(-c2ccnn2C)c2ccnc(-c3ccnn3[C@H]3CCCCO3)c2n1
InChIInChI=1S/2C25H29N7O2/c2*1-17-16-33-14-12-31(17)22-15-19(20-7-10-27-30(20)2)18-6-9-26-25(24(18)29-22)21-8-11-28-32(21)23-5-3-4-13-34-23/h2*6-11,15,17,23H,3-5,12-14,16H2,1-2H3/t17-,23+;17-,23-/m11/s1
InChIKeyKFMZNRDEOJMDHE-DEIXQTLHSA-N
MW919.11 g/mol
LogP7.64
Rot. Bonds8

About (3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-[2-[(2R)-oxan-2-yl]pyrazol-3-yl]-1,7-naphthyridin-2-yl]morpholine;(3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-[2-[(2S)-oxan-2-yl]pyrazol-3-yl]-1,7-naphthyridin-2-yl]morpholine

(3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-[2-[(2R)-oxan-2-yl]pyrazol-3-yl]-1,7-naphthyridin-2-yl]morpholine;(3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-[2-[(2S)-oxan-2-yl]pyrazol-3-yl]-1,7-naphthyridin-2-yl]morpholine (PubChem CID 159119539) has the molecular formula C50H58N14O4 and a molecular weight of 919.11 g/mol. Its IUPAC name is (3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-[2-[(2R)-oxan-2-yl]pyrazol-3-yl]-1,7-naphthyridin-2-yl]morpholine;(3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-[2-[(2S)-oxan-2-yl]pyrazol-3-yl]-1,7-naphthyridin-2-yl]morpholine.

Molecular Properties

Compound Name(3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-[2-[(2R)-oxan-2-yl]pyrazol-3-yl]-1,7-naphthyridin-2-yl]morpholine;(3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-[2-[(2S)-oxan-2-yl]pyrazol-3-yl]-1,7-naphthyridin-2-yl]morpholine
PubChem CID159119539
Molecular FormulaC50H58N14O4
Molecular Weight919.11 g/mol
Exact Mass918.48
IUPAC Name(3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-[2-[(2R)-oxan-2-yl]pyrazol-3-yl]-1,7-naphthyridin-2-yl]morpholine;(3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-[2-[(2S)-oxan-2-yl]pyrazol-3-yl]-1,7-naphthyridin-2-yl]morpholine
SMILESC[C@@H]1COCCN1c1cc(-c2ccnn2C)c2ccnc(-c3ccnn3[C@@H]3CCCCO3)c2n1.C[C@@H]1COCCN1c1cc(-c2ccnn2C)c2ccnc(-c3ccnn3[C@H]3CCCCO3)c2n1
InChIInChI=1S/2C25H29N7O2/c2*1-17-16-33-14-12-31(17)22-15-19(20-7-10-27-30(20)2)18-6-9-26-25(24(18)29-22)21-8-11-28-32(21)23-5-3-4-13-34-23/h2*6-11,15,17,23H,3-5,12-14,16H2,1-2H3/t17-,23+;17-,23-/m11/s1
InChIKeyKFMZNRDEOJMDHE-DEIXQTLHSA-N
XLogP7.64
TPSA166.24 Ų
H-Bond Donors
H-Bond Acceptors18
Rotatable Bonds8
Heavy Atoms68
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500919.11
LogP ≤ 57.64
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1018

Analyze (3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-[2-[(2R)-oxan-2-yl]pyrazol-3-yl]-1,7-naphthyridin-2-yl]morpholine;(3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-[2-[(2S)-oxan-2-yl]pyrazol-3-yl]-1,7-naphthyridin-2-yl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-[2-[(2R)-oxan-2-yl]pyrazol-3-yl]-1,7-naphthyridin-2-yl]morpholine;(3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-[2-[(2S)-oxan-2-yl]pyrazol-3-yl]-1,7-naphthyridin-2-yl]morpholine?
The IUPAC name of (3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-[2-[(2R)-oxan-2-yl]pyrazol-3-yl]-1,7-naphthyridin-2-yl]morpholine;(3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-[2-[(2S)-oxan-2-yl]pyrazol-3-yl]-1,7-naphthyridin-2-yl]morpholine (CID 159119539) is (3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-[2-[(2R)-oxan-2-yl]pyrazol-3-yl]-1,7-naphthyridin-2-yl]morpholine;(3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-[2-[(2S)-oxan-2-yl]pyrazol-3-yl]-1,7-naphthyridin-2-yl]morpholine.
What is the SMILES notation for (3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-[2-[(2R)-oxan-2-yl]pyrazol-3-yl]-1,7-naphthyridin-2-yl]morpholine;(3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-[2-[(2S)-oxan-2-yl]pyrazol-3-yl]-1,7-naphthyridin-2-yl]morpholine?
The canonical SMILES for (3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-[2-[(2R)-oxan-2-yl]pyrazol-3-yl]-1,7-naphthyridin-2-yl]morpholine;(3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-[2-[(2S)-oxan-2-yl]pyrazol-3-yl]-1,7-naphthyridin-2-yl]morpholine is C[C@@H]1COCCN1c1cc(-c2ccnn2C)c2ccnc(-c3ccnn3[C@@H]3CCCCO3)c2n1.C[C@@H]1COCCN1c1cc(-c2ccnn2C)c2ccnc(-c3ccnn3[C@H]3CCCCO3)c2n1.
What is the InChIKey of (3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-[2-[(2R)-oxan-2-yl]pyrazol-3-yl]-1,7-naphthyridin-2-yl]morpholine;(3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-[2-[(2S)-oxan-2-yl]pyrazol-3-yl]-1,7-naphthyridin-2-yl]morpholine?
The InChIKey is KFMZNRDEOJMDHE-DEIXQTLHSA-N. The full InChI is InChI=1S/2C25H29N7O2/c2*1-17-16-33-14-12-31(17)22-15-19(20-7-10-27-30(20)2)18-6-9-26-25(24(18)29-22)21-8-11-28-32(21)23-5-3-4-13-34-23/h2*6-11,15,17,23H,3-5,12-14,16H2,1-2H3/t17-,23+;17-,23-/m11/s1.
What are the key properties of (3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-[2-[(2R)-oxan-2-yl]pyrazol-3-yl]-1,7-naphthyridin-2-yl]morpholine;(3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-[2-[(2S)-oxan-2-yl]pyrazol-3-yl]-1,7-naphthyridin-2-yl]morpholine?
(3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-[2-[(2R)-oxan-2-yl]pyrazol-3-yl]-1,7-naphthyridin-2-yl]morpholine;(3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-[2-[(2S)-oxan-2-yl]pyrazol-3-yl]-1,7-naphthyridin-2-yl]morpholine has a molecular weight of 919.11 g/mol, XLogP of 7.64, 8 rotatable bonds, 0 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for (3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-[2-[(2R)-oxan-2-yl]pyrazol-3-yl]-1,7-naphthyridin-2-yl]morpholine;(3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-[2-[(2S)-oxan-2-yl]pyrazol-3-yl]-1,7-naphthyridin-2-yl]morpholine is sourced from PubChem (CID 159119539), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).